Jin Medical director files initial Form 3

Jin Medical International Ltd. director Guo Yanru has filed an initial Form 3 as a reporting person for the company’s shares.

Rhea-AI Filing Summary

Jin Medical International Ltd. director Guo Yanru has filed an initial Form 3 as a reporting person for the company’s shares. The filing shows no reported share transactions, no derivative transactions, and no holding entries in this excerpt, effectively establishing a baseline for future insider ownership reports.

Key Figures

Buy shares reported: 0 shares Sell shares reported: 0 shares Net buy/sell shares: 0 shares

3 metrics

Buy shares reported 0 shares Form 3 transaction summary

Sell shares reported 0 shares Form 3 transaction summary

Net buy/sell shares 0 shares Form 3 transaction summary (neutral direction)

Key Terms

Form 3, reporting person, derivative transactions

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3):"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting person regulatory

""reportingPersons": [ { "name": "Guo Yanru""

derivative transactions financial

""derivativeTransactionCount": 0"

Derivative transactions are contracts whose value depends on the price or performance of something else—like stocks, bonds, currencies, interest rates or commodities. Think of them as insurance or bets about a future price: investors use them to protect against losses, lock in prices, or try to amplify returns, but they can also magnify losses, create cash demands and expose a firm to the risk that the other party won’t meet its obligation, so they can materially affect a company’s financial stability and volatility.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Jin Medical (ZJYL) Form 3 filing by Guo Yanru show?

The Form 3 shows that director Guo Yanru has become a reporting person for Jin Medical International Ltd.. The excerpt lists no transactions, derivative positions, or holding entries, serving mainly as an initial ownership baseline.

Did Guo Yanru buy or sell any Jin Medical (ZJYL) shares in this Form 3?

No share purchases or sales are reported for Guo Yanru in this Form 3. The transaction summary shows 0 buy shares, 0 sell shares, and a net buy/sell share count of 0 in this excerpt.

Are there any derivative securities reported for Jin Medical (ZJYL) in this Form 3?

The filing excerpt shows no derivative securities reported for Guo Yanru. The derivative summary is empty and the transaction summary lists 0 derivative transactions, indicating no options, warrants, or similar instruments disclosed here.

What does a net buy/sell direction of neutral mean for Jin Medical (ZJYL)?

A neutral net buy/sell direction means there were no net share purchases or sales reported. For this Form 3, buy shares, sell shares, and net buy/sell shares are all 0, so the filing is purely an initial reporting step.

What role does reporting person Guo Yanru have at Jin Medical (ZJYL)?

The filing identifies Guo Yanru as a director of Jin Medical International Ltd. Being a director makes them a reporting person who must disclose insider holdings and future transactions in company securities under SEC rules.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/24/2026 - 10:44 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Guo Yanru

(Last) (First) (Middle)

C/O JIN MEDICAL INTERNATIONAL LTD.

NO. 33 LINGXIANG ROAD, WUJIN DISTRICT

(Street)

CHANGZHOU JIANGSU

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Jin Medical International Ltd. [ ZJYL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Yanru Guo	04/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)